NAT2 Back

N-acetyltransferase 2 (arylamine N-acetyltransferase)

External References:      Wikipedia GeneCards HUGO COSMIC Google Scholar

NCBI Description of NAT2
This gene encodes an enzyme that functions to both activate and deactivate arylamine and hydrazine drugs and carcinogens. Polymorphisms in this gene are responsible for the N-acetylation polymorphism in which human populations segregate into rapid, intermediate, and slow acetylator phenotypes. Polymorphisms in this gene are also associated with higher incidences of cancer and drug toxicity. A second arylamine N-acetyltransferase gene (NAT1) is located near this gene (NAT2).

Community Annotation of NAT2 Add / Edit NAT2: Annotations

No community annotations yet for NAT2.
Sort mutations by: Tumor type  Mutation type  Position  
Straightedge cursor Expand

Figure notes


• "Mouse over" a mutation to see details.
• Missense green saturation indicates evolutionary conservation of the mutated positions.
• Red hashes in protein strip are splice sites.
• Blue-white-red bars are log2 copy ratio distributions (–1 to +1) from Zack et al. (2013).


Legend

NAT2 is highly significantly mutated in
(none)
NAT2 is significantly mutated in
(none)
NAT2 is near significance in
(none)

Click on a tumor type to see its full list of significant genes.

Data details


• Mutation list for NAT2